Stem Cell Research for Neuropathy

Stem cell therapy for Neuropathy is becoming an option for patients in the US. Neuropathy is a condition that may impact movement, sensation, and other functions due to affected nerves, it is often a consequence of other diseases. It can begin in a subtle manner and progressively become worse for the patient, even chronic. Neuropathy can also cause pain to muscles, joints, bones, as well as impact balance and other basic functions.

There are many clinical studies that demonstrate the positive outcomes that patients may reach with the right treatment. Regenerative therapy may be a safe, effective treatment that does not carry the same risk as surgery. It is often called stem cell therapy. 

Stem cell therapy has shown, in scientific trials on patients, how the treatment may provide a solution to families struggling with this condition. The latest research demonstrates that patients with Neuropathy may be helped using stem cell therapy.  There are also ongoing clinical trials testing this treatment on patients. We invite you to see further details about this treatment from clinics that have already treated patients and show results.

Stem cell therapy for Neuropathy has been practiced overseas for years and may bring positive outcomes to families dealing with Neuropathy.  You will find on our website clinics that use this treatment and can better answer your questions regarding this procedure and how it impacts your health.

Not only is stem cell therapy a plausible treatment for patients with Neuropathy, it is much more affordable than the medications that are often prescribed to patients. Please watch this space as we continue to vet clinics that you may choose for this transformative therapy and return to a better quality of life without the financial burden too often a consequence when seeking healthcare. It seems that this therapy is not yet fully approved by the FDA for everyone and is allowed for some patient cases. Please check back regularly as we update this information. 

 

 

 

0 0 votes
Rating